Tema Heart & Health ETF (HRTS) Holdings $29.50 +0.07 (+0.24%) As of 01:18 PM Eastern Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Top 25 HRTS HoldingsRankCompanyCurrent PriceWeightShares Held1LLYEli Lilly and Company$713.52+1.1%10.06%6,2152ABTAbbott Laboratories$132.64+0.1%4.75%17,5773AstraZeneca PLCN/A4.36%13,9514RHHBYRoche$40.61-0.3%4.03%48,9245GILDGilead Sciences$117.30-1.2%3.55%14,7956UNHUnitedHealth Group$304.63+1.6%3.51%6,9537BBIOBridgeBio Pharma$49.64+1.6%3.50%34,8088MDTMedtronic$92.40-0.9%3.48%18,3589ABBVAbbVie$211.94+1.3%3.47%8,38310BSXBoston Scientific$105.60-0.4%3.34%14,910 Get the Latest News and Ratings for HRTS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tema Heart & Health ETF and its competitors with MarketBeat's FREE daily newsletter. 11TMOThermo Fisher Scientific$489.87-1.0%3.31%3,36912Novartis AGN/A3.21%12,93613Novo Nordisk A/SN/A3.14%30,86914VRTXVertex Pharmaceuticals$397.11+0.7%2.83%2,88715AMGNAmgen$298.51+0.7%2.67%4,23016CRNXCrinetics Pharmaceuticals$29.36+0.9%2.51%42,50517MRKMerck & Co., Inc.$87.04+2.8%2.49%14,81118DHRDanaher$207.40-1.9%2.35%5,61619Chugai Pharmaceutical Co., Ltd.N/A2.32%21,92120ALNYAlnylam Pharmaceuticals$466.05+1.7%2.29%2,68721REGNRegeneron Pharmaceuticals$604.65+2.3%2.18%1,83822PODDInsulet$331.51-0.4%2.05%3,39423BMYBristol Myers Squibb$48.83+1.2%1.98%21,06424MCKMcKesson$705.75+0.4%1.95%1,31525EWEdwards Lifesciences$82.04+0.8%1.93%11,435 Geographic ExposureUnited States82.4%Denmark4.7%United Kingdom4.5%Switzerland3.3%Ireland3.1%Japan1.9%Currency ExposureUSD88.9%GBP4.5%CHF3.3%JPY1.9%DKK1.3%Sector ExposureHealth Care95.9%Consumer Discretionary3.4%Industry ExposureBiotechnology60.5%Health Care Equipment & Supplies25.2%Health Care Providers & Services4.6%Pharmaceuticals3.8%Textiles, Apparel & Luxury Goods3.4%Health Care Technology1.9%SubIndustry ExposureBiotechnology56.2%Health Care Equipment14.2%Life Sciences Tools & Services10.5%Pharmaceuticals8.1%Managed Health Care4.6%Apparel, Accessories & Luxury Goods3.4%Health Care Distributors1.9%Health Care Supplies0.5% Related Companies and Tools Related Companies Siren Nasdaq NexGen Economy ETF Portfolio Companies Democratic Large Cap Core ETF Portfolio Companies Global X Genomics & Biotechnology ETF Portfolio Companies Fidelity Metaverse ETF Portfolio Companies Relative Sentiment Tactical Allocation ETF Portfolio Companies First Trust Dow Jones International Internet ETF Portfolio Companies Fidelity Disruptive Medicine ETF Portfolio Companies Lazard Next Gen Technologies ETF Portfolio Companies Fidelity Disruptive Finance ETF Portfolio Companies KraneShares Artificial Intelligence and Technology ETF Portfolio Companies This page (NASDAQ:HRTS) was last updated on 8/21/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Heart & Health ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Heart & Health ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access